Print

Tiantan vaccinia HIV Vaccine and DNA

NCT01705223

Trial Details:

II Completed
National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), National Sera and Vaccine Institute
Tiantan vaccinia ,Chinese DNA
RandD/trials/Lists/ClinicalTrialsList
1/1/2015
Replicating Tiantan vaccinia clade B'/C, combined with DNA, CN54 CRF-07 gag, pol, env
DNA vaccine prime with the addition of electroporation at week 0, 4, 8 and rTV boost at week 24 DNA vaccine prime at week 0,4,8 and rTV boost at week 16,  24, or 32